FindMyRecallSubscribe
Class I: serious health riskOngoing

Teligent Pharma Lidocaine Hydrochloride Topical Solution Recall

Lidocaine Hydrochloride Topical Solution, USP, 4% , 50 mL glass bottles, Rx Only, Telig…

Teligent Pharma, Inc. · Buena, NJ

Risk level
Class I
Reported by FDA
Sep 22, 2021
Recall ID
D-0800-2021
Check your lot numberHow we source this data

Summary

Teligent Pharma recalled Lidocaine Hydrochloride Topical Solution starting Aug 3, 2021. The FDA classified it as Class I (serious health risk) and published enforcement report D-0800-2021 on Sep 22, 2021. Reason: Superpotent Drug. Status: Ongoing.

Why it was recalled

Superpotent Drug

Product description

Lidocaine Hydrochloride Topical Solution, USP, 4% , 50 mL glass bottles, Rx Only, Teligent Pharma Inc. Buena, New Jersey 08310, NDC 52565-009-50.

Lot numbers, UPCs & expiration codes

Lot #:14218, Exp. Date 08/2022

Where it was sold

Nationwide within the United States and Canada

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0800-2021
Classification
Class I
Status
Ongoing
Recall initiated
Aug 3, 2021
FDA report date
Sep 22, 2021
Quantity
32,544 glass bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Teligent Pharma, Inc.

Original FDA data

Every field from FDA enforcement report D-0800-2021, exactly as published.

Show all FDA fields
City
Buena
State
NJ
Status
Ongoing
Country
United States
Event ID
88454
Address
105 Lincoln Avenue
Code information
Lot #:14218, Exp. Date 08/2022
Postal code
08310
Report date
Sep 22, 2021
Product type
Drugs
Recall number
D-0800-2021
Classification
Class I
Recalling firm
Teligent Pharma, Inc.
Product quantity
32,544 glass bottles
Reason for recall
Superpotent Drug
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lidocaine Hydrochloride Topical Solution, USP, 4% , 50 mL glass bottles, Rx Only, Teligent Pharma Inc. Buena, New Jersey 08310, NDC 52565-009-50.
Distribution pattern
Nationwide within the United States and Canada
Recall initiation date
Aug 3, 2021
Initial firm notification
Letter
Center classification date
Sep 15, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0800-2021, published Sep 22, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls